Project description
Pioneering mRNA therapy could promote healing and reduce loss of vision
Messenger RNA (mRNA) plays a pivotal role in gene expression. During transcription, the code carried in DNA is copied to a single strand of mRNA. The mRNA is then used as a template to assemble the appropriate sequence of amino acids into the protein. INSIGHT EU has developed a proprietary mRNA-delivery platform that is already being used to treat chronic kidney disease. The project has now turned its sights to treatments for impaired vision and blindness. Development of mRNA therapies delivered to the eye could promote healing and ameliorate vision loss. Success could open a new window on life for millions with impaired vision.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesclinical medicineophthalmologyglaucoma
- medical and health sciencesclinical medicinesurgery
- medical and health sciencesclinical medicineophthalmologyretinopathy
- natural sciencesbiological sciencesgeneticsRNA
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
6673 DR Andelst
Netherlands
See on map